B. Metzler Seel. Sohn & Co. Holding Ag Lantheus Holdings, Inc. Transaction History
B. Metzler Seel. Sohn & Co. Holding Ag
- $10.1 Trillion
- Q3 2024
A detailed history of B. Metzler Seel. Sohn & Co. Holding Ag transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, B. Metzler Seel. Sohn & Co. Holding Ag holds 19,367 shares of LNTH stock, worth $1.63 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
19,367Holding current value
$1.63 Million% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding LNTH
# of Institutions
524Shares Held
67.4MCall Options Held
1.19MPut Options Held
837K-
Black Rock Inc. New York, NY8.6MShares$723 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.57MShares$636 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X03.33MShares$280 Million0.15% of portfolio
-
State Street Corp Boston, MA2.49MShares$209 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA2.28MShares$192 Million0.89% of portfolio
About Lantheus Holdings, Inc.
- Ticker LNTH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 68,741,904
- Market Cap $5.78B
- Description
- Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...